Literature DB >> 22546381

Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.

Scott D Ramsey1, Steven B Zeliadt, David K Blough, Catherine R Fedorenko, Megan E Fairweather, Cara L McDermott, David F Penson, Stephen K Van Den Eeden, Ann S Hamilton, Neeraj K Arora.   

Abstract

OBJECTIVE: To evaluate the association between complementary and alternative medicine (CAM) use, satisfaction with treatment, and patient-reported outcomes after treatment.
METHODS: The Prostate CAncer Therapy Selection Study prospectively surveyed patients newly diagnosed with localized prostate cancer about their treatment decision-making process and outcomes. The Prostate CAncer Therapy Selection Study recruited patients from 3 geographic areas through hospital-based urology clinics and community urology practices.
RESULTS: More than 700 patients completed the baseline and follow-up surveys. More than 50% of respondents reported using CAM; this decreased to 39% if prayer was excluded as a type of CAM. On multivariate analysis, factors related to communication with the treating physician, but not CAM use, were associated with treatment satisfaction. The likelihood of stability or improvement in urinary, bowel, and sexual function at 6 months was related to the choice of primary therapy but was unrelated to CAM use.
CONCLUSION: In the present prospective observational study, CAM use was highly prevalent but unrelated to treatment satisfaction or changes in functional status. The effect of CAM on these endpoints remains to be established in comparative effectiveness studies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22546381      PMCID: PMC3489914          DOI: 10.1016/j.urology.2012.01.023

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  26 in total

Review 1.  Body, mind and spirit: towards the integration of religiosity and spirituality in cancer quality of life research.

Authors:  J J Mytko; S J Knight
Journal:  Psychooncology       Date:  1999 Sep-Oct       Impact factor: 3.894

2.  Preliminary treatment considerations among men with newly diagnosed prostate cancer.

Authors:  Steven B Zeliadt; Carol M Moinpour; David K Blough; David F Penson; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Ian M Thompson; Thomas E Keane; Scott D Ramsey
Journal:  Am J Manag Care       Date:  2010-05-01       Impact factor: 2.229

3.  Determinants of long-term sexual health outcome after radical prostatectomy measured by a validated instrument.

Authors:  Brent K Hollenbeck; Rodney L Dunn; John T Wei; James E Montie; Martin G Sanda
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.

Authors:  J T Wei; R L Dunn; M S Litwin; H M Sandler; M G Sanda
Journal:  Urology       Date:  2000-12-20       Impact factor: 2.649

5.  Bowel function and bother after treatment for early stage prostate cancer: a longitudinal quality of life analysis from CaPSURE.

Authors:  Mark S Litwin; Natalia Sadetsky; David J Pasta; Deborah P Lubeck
Journal:  J Urol       Date:  2004-08       Impact factor: 7.450

6.  Frequent use of complementary medicine by prostate cancer patients.

Authors:  Anton Ponholzer; Gerhard Struhal; Stephan Madersbacher
Journal:  Eur Urol       Date:  2003-06       Impact factor: 20.096

7.  Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.

Authors:  Katsuya Tasaki; Gertraud Maskarinec; Dianne M Shumay; Yvonne Tatsumura; Hisako Kakai
Journal:  Psychooncology       Date:  2002 May-Jun       Impact factor: 3.894

Review 8.  On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer.

Authors:  Scott D Ramsey; Steven B Zeliadt; Ingrid J Hall; Donatus U Ekwueme; David F Penson
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

9.  Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics.

Authors:  Heather Boon; Kathleen Westlake; Moira Stewart; Ross Gray; Neil Fleshner; Alan Gavin; Judith Belle Brown; Vivek Goel
Journal:  Urology       Date:  2003-11       Impact factor: 2.649

Review 10.  Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies.

Authors:  F L Bishop; A Rea; H Lewith; Y K Chan; J Saville; P Prescott; E von Elm; G T Lewith
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-10-19       Impact factor: 5.554

View more
  2 in total

1.  [Importance of complementary medicine approaches for patients with prostate cancer].

Authors:  K M Gschwendtner; G Klein; C Güthlin; C Holmberg; M Horneber; J Weis
Journal:  Urologe A       Date:  2014-11       Impact factor: 0.639

2.  Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.

Authors:  Kyle B Zuniga; Shoujun Zhao; Stacey A Kenfield; Benjamin Cedars; Janet E Cowan; Erin L Van Blarigan; Jeanette M Broering; Peter R Carroll; June M Chan
Journal:  J Urol       Date:  2019-09-06       Impact factor: 7.450

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.